Alzheimer's therapeutics targeting Amyloid Beta 1'42 oligomers II: Sigma-2/PGRMC1 receptors mediate Abeta 42 Oligomer binding and synaptotoxicity

Nicholas J. Izzo, Jinbin Xu, Chenbo Zeng, Molly J. Kirk, Kelsie Mozzoni, Colleen Silky, Courtney Rehak, Raymond Yurko, Gary Look, Gilbert Rishton, Hank Safferstein, Carlos Cruchaga, Alison Goate, Michael Cahill, Ottavio Arancio, Robert H. Mach, Rolf Craven, Elizabeth Head, Harry Levine III, Tara L. Spires-JonesSusan M. Catalano

Research output: Contribution to journalArticlepeer-review

101 Citations (Scopus)
18 Downloads (Pure)

Fingerprint Dive into the research topics of 'Alzheimer's therapeutics targeting Amyloid Beta 1'42 oligomers II: Sigma-2/PGRMC1 receptors mediate Abeta 42 Oligomer binding and synaptotoxicity'. Together they form a unique fingerprint.

Medicine & Life Sciences

Agriculture & Biology

Chemical Compounds